FDA inspection
GlaxoSmithKline LLC: FDA inspection ending Sep 18, 2006
FDA inspection 442442 · No Action Indicated (NAI) · East Durham, NY
Key facts
| Inspection ID | 442442 |
|---|---|
| Firm | GlaxoSmithKline LLC |
| FEI number | 1314819 |
| Address | 3169 Route 145 |
| City | East Durham |
| State | NY |
| ZIP | 12423-1416 |
| Fiscal year | 2006 |
| Inspection end date | Sep 18, 2006 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data